ASHLEY BLACKBURN: Open Payments
NPI 1427822378 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,049 in 51 payments from 15 companies in 2025. Trend: 2023 $59 · 2024 $2,222 · 2025 $1,049
Food & beverage: $1,049
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $262 |
| AstraZeneca Pharmaceuticals LP | 9 | $142 |
| ABBVIE INC. | 7 | $140 |
| PFIZER INC. | 7 | $138 |
| GlaxoSmithKline, LLC. | 3 | $77 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Abbott Laboratories | 3 | $57 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
Products named: Ozempic, UBRELVY, Wegovy, NURTEC ODT, LEQVIO, AIRSUPRA, FARXIGA, ELIQUIS.
Industry payments across PA — which companies pay providers there.
